Evidence map›Paper›PMID 40100208›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2025

PoWeR elicits intracellular signaling, mitochondrial adaptations, and hypertrophy in multiple muscles consistent with endurance and resistance exercise training.

Christian J Elliehausen, Szczepan S Olszewski, Dennis M Minton, Audrey L Spiegelhoff, Carolyn G Shult, Wenyuan G Zhu, Troy A Hornberger, Adam R Konopka

Abstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. The Sixth Annual Symposium of the Midwest Aging Consortium.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  3. The response of glutathione oxidase and cytochromeBiochemistry and biophysics reports · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christian J ElliehausenDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States.
Szczepan S OlszewskiDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States.ORCID 0000-0002-9280-5548
Dennis M MintonDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States.
Audrey L SpiegelhoffDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States.
Carolyn G ShultDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States.
Wenyuan G ZhuDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, Wisconsin, United States.
Troy A HornbergerDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, Wisconsin, United States.
Adam R KonopkaDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States.ORCID 0000-0001-6655-6747

Funding

Biology of Aging and Age-Related Diseases Training GrantT32AG000213 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Rozalyn M. Anderson, Sanjay Asthana · 1991 to 2026
$9.9M
Clinical evaluation of mTORC1 inhibition for geroprotection.U01AG076941 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI KONOPKA, ADAM R · 2022 to 2024
$4.3M
Identifying the Structural Adaptations that Drive the Mechanically Induced Growth of Skeletal MuscleR01AR082816 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI TROY A HORNBERGER · 2023 to 2026
$1.9M
Safer mTOR inhibition for human geroprotectionU01AG081482 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Adam R Konopka, Dudley William Lamming · 2023 to 2026
$1.8M
Hevolution/American Federation for Aging Research 035HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR082816HHS | NIH | National Institute on Aging (NIA) T32-AG000213HHS | NIH | National Institute on Aging (NIA) U01AG076941HHS | NIH | National Institute on Aging (NIA) U01AG081482NIAMS NIH HHS R01 AR082816NIA NIH HHS T32 AG000213NIA NIH HHS U01 AG076941NIA NIH HHS U01 AG081482UW | School of Medicine and Public Health, University of Wisconsin-Madison (UWSMPH)
6 · The paper itself

Abstract

Physical activity guidelines recommend both endurance and resistance exercise to improve and maintain overall health. Recently, progressive weighted wheel running (PoWeR), a voluntary, progressive, and high-volume exercise paradigm, was posited as a singular prototype of combined endurance and resistance exercise in mice as evident by enhanced capillarization and hypertrophy of select plantar flexor muscles. Despite growing interest in this model, it remains incompletely characterized if PoWeR resembles the acute and chronic responses to resistance and/or endurance exercise in humans. Therefore, the purpose of this study was to assess canonical signaling events, mitochondrial bioenergetics, and cellular adaptations across multiple extensor and flexor muscles of the fore- and hindlimbs that may be conducive for whole-body functional improvements as traditionally observed in humans. Eight weeks of PoWeR (∼8 km/day) improved glucose metabolism, exercise capacity, body composition, and bone mineral density as well as increased mass, myofiber cross-sectional area (CSA), and oxidative myofiber type distribution in the soleus, plantaris, and flexor digitorum longus (FDL). Using two ex vivo high-resolution fluororespirometry protocols that model in vivo physiological conditions, PoWeR decreased mitochondrial ADP sensitivity which was accompanied by greater mitochondrial H

Indexed as

Adaptation, PhysiologicalMitochondria, MuscleMotor ActivityMuscle, SkeletalPhysical Conditioning, AnimalPhysical EnduranceAMP-Activated Protein KinasesAnimalsBlood GlucoseBody CompositionBone DensityEndurance TrainingEnergy MetabolismFemaleForelimbHindlimbAMP-Activated Protein KinasesBlood GlucoseMechanistic Target of Rapamycin Complex 1hypertrophymetabolismmitochondriamTORreactive oxygen species

Identifiers

PMID40100208
PMCPMC12323402

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.